Abatacept for the treatment of rheumatoid arthritis: A review
- 31 December 2007
- journal article
- Published by Elsevier BV in Current Therapeutic Research
- Vol. 68 (6), 379-399
- https://doi.org/10.1016/j.curtheres.2007.12.001
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factorNature Clinical Practice Rheumatology, 2006
- Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease‐modifying antirheumatic drugs: A one‐year randomized, placebo‐controlled studyArthritis & Rheumatism, 2006
- Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effectsAnnals Of The Rheumatic Diseases, 2006
- Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatmentAnnals Of The Rheumatic Diseases, 2006
- Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trialAnnals Of The Rheumatic Diseases, 2006
- The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritisExpert Opinion on Investigational Drugs, 2003
- Lymphomas in Patients With Connective Tissue DiseaseAmerican Journal of Clinical Pathology, 2000
- Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographsArthritis & Rheumatism, 1998
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992